Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

9.93
BATS BZX Real-Time Price
As of 3:31pm ET
 +0.47 / +4.97%
Today’s Change
7.09
Today|||52-Week Range
11.47
+19.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues10.3M9.1M29.7M52.5M
 
 
 
 
 
Cost of Goods Sold852.0K267.0K1.4M1.1M
 
 
 
 
 
Depreciation And Amortization215.0K227.0K233.0K241.0K
 
 
 
 
 
 
Operating ExpensesGross Income9.3M8.6M28.0M51.2M
 
 
 
 
 
General Expenses20.6M22.0M24.3M22.0M
 
 
 
 
 
Research And Development5.4M4.5M4.7M4.7M
 
 
 
 
 
Total Operating Expenses21.7M22.5M25.9M23.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.4M-13.4M3.8M29.2M
 
 
 
 
 
Extraordinary Credit0.00677.0K678.0K760.0K
 
 
 
 
Extraordinary Charge-9.1M-1.7M-39.0K-860.0K
 
 
 
 
 
Interest Expense On Debt2.1M1.2M1.3M1.3M
 
 
 
 
 
Other Expenses12.0K0.000.002.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.4M-15.5M3.2M27.9M
 
 
 
 
 
Net Income-22.4M-15.5M3.2M27.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.6M41.1M42.1M42.9M
 
 
 
 
 
Shares To Calculate EPS Diluted34.6M41.1M42.4M50.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.65-$0.38$0.08$0.39
 
 
 
 
 
EPS Diluted-$0.65-$0.38$0.08$0.39
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account